NCT02946307 - Assess the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

May 31, 2019

Conditions

Coronary Stenosis

Interventions

DEVICE

Restore DEB（dimeter>2.00 mm）

DEVICE

Resolute DES

DEVICE

Restore DEB（dimeter:2.00 mm）

Trial Locations (12)

100029

Beijing Anzhen Hospital,Capital Medical University, Beijing

100037

Fuwai Hospital, CAMS&PUMC, Beijing

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

100853

Chinese PLA General Hospital, Beijing

110004

Shengjing Hospital of China Medical University, Shenyang

163000

Daqing Oilfield General Hospital, Daqing

210008

Nanjing Drum Tower Hospital, The Affiliated Hospital of Najing University Medical School, Nanjing

210029

Jiangsu Province Hospital, Nanjing

300140

Tianjin 4th Centre Hospital, Tianjin

410008

Xiangya Hospital Central South University, Changsha

430022

Wuhan Asia Heart Hospital, Wuhan

710038

Tangdu Hospital, Xi'an

All Listed Sponsors

collaborator

R&G Pharma Studies Co.,Ltd.

INDUSTRY

lead

ZhuHai Cardionovum Medical Device Co., Ltd.

INDUSTRY